Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Venetoclax is a drug used to treat chronic lymphocytic leukemia (CLL) and certai···【more】
Release date：2024-08-09Recommended：232
Capmatinib is a targeted drug manufactured by Novartis for the treatment of pati···【more】
Release date：2024-08-09Recommended：219
Capmatinib, trade name Tabrecta. It is an oral MET inhibitor mainly used for the···【more】
Release date：2024-08-09Recommended：221
Capmatinib is an oral, selective, ATP-competitive c-Met kinase inhibitor that in···【more】
Release date：2024-08-09Recommended：245
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.H···【more】
Release date：2024-08-09Recommended：185
Capmatinib is a lung cancer drug that targets specific genetic mutations, especi···【more】
Release date：2024-08-09Recommended：228
Pemigatinibis a targeted drug for the treatment of cholangiocarcinoma and belong···【more】
Release date：2024-08-09Recommended：217
Capmatinib is a targeted therapy for the treatment of non-small cell lung cancer···【more】
Release date：2024-08-09Recommended：235
Exkivity reduces the growth of non-small cell lung cancer by binding to and inhi···【more】
Release date：2024-08-09Recommended：195
Exkivity works by binding to and blocking EGFR exon 20 insertion mutations, whic···【more】
Release date：2024-08-09Recommended：225
Exkivity was granted accelerated FDA approval in 2021 based on results from the ···【more】
Release date：2024-08-09Recommended：243
Exkivity capsules can be used by adults with non-small cell lung cancer that has···【more】
Release date：2024-08-09Recommended：179
